ArticleCancer immunology, immunotherapy : CII2026

Downregulation of B7-H4 contributes to the synergistic effect of USP2a-targeted/anti-PD-1 combination therapy in EGFR mutant lung cancer.

Boshu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.